Ian has over 30 years of executive experience and specializes in scaling and managing technology businesses. He started his career at SST, where he led the company’s growth from start-up to over $25M in revenue. Since then, he has held a number of other C-level positions at $10M+ software businesses.
Ian is pleased to be an investor in BeMe as well as its CFO, where he will works with the executive team on financing and strategy.
Ian has over 30 years of executive experience and specializes in scaling and managing technology businesses. He started his career at SST, where he led the company’s growth from start-up to over $25M in revenue. Since then, he has held a number of other C-level positions at $10M+ software businesses.
Ian is pleased to be an investor in BeMe as well as its CFO, where he will works with the executive team on financing and strategy.
Ian has over 30 years of executive experience and specializes in scaling and managing technology businesses. He started his career at SST, where he led the company’s growth from start-up to over $25M in revenue. Since then, he has held a number of other C-level positions at $10M+ software businesses.
Ian is pleased to be an investor in BeMe as well as its CFO, where he will works with the executive team on financing and strategy.
Bassem has worked in clinical practice, academia, and industry. In additional to having practiced Medicine, he holds an MSc degree in Experimental Therapeutics at the University of Oxford, UK, an MSc degree in Experimental Medicine at McGill University, Canada, and a PhD degree in health technology assessment at the University of Toronto, Canada.
Bassem has spent 28 years in diverse roles in hospital/healthcare, clinical research, pharmaceutical, medical device, biotechnology, and education. He is a WHO consultant, CEO and Founder of MD Pharma Consulting Group, ECFMG and LMCC Licensing Exams Program Director at Edge Plus Inc., health economist, pharmacovigilance consultant, clinical research instructor, and a mentor.
His areas of research include internal medicine, medical oncology, epidemiology, pharmacovigilance, health technology assessment, decision analysis, and benefit-risk assessment. My skills include bridging the gap between academia and industry, efficient resource allocation, time management, and task prioritization.
Bassem’s hardworking and persevering nature and compassionate demeanor make Bassem a sincere and passionate advocate for BeMe and Autistic individuals.
Bassem has worked in clinical practice, academia, and industry. In additional to having practiced Medicine, he holds an MSc degree in Experimental Therapeutics at the University of Oxford, UK, an MSc degree in Experimental Medicine at McGill University, Canada, and a PhD degree in health technology assessment at the University of Toronto, Canada.
Bassem has spent 28 years in diverse roles in hospital/healthcare, clinical research, pharmaceutical, medical device, biotechnology, and education. He is a WHO consultant, CEO and Founder of MD Pharma Consulting Group, ECFMG and LMCC Licensing Exams Program Director at Edge Plus Inc., health economist, pharmacovigilance consultant, clinical research instructor, and a mentor.
His areas of research include internal medicine, medical oncology, epidemiology, pharmacovigilance, health technology assessment, decision analysis, and benefit-risk assessment. My skills include bridging the gap between academia and industry, efficient resource allocation, time management, and task prioritization.
Bassem’s hardworking and persevering nature and compassionate demeanor make Bassem a sincere and passionate advocate for BeMe and Autistic individuals.
Bassem has worked in clinical practice, academia, and industry. In additional to having practiced Medicine, he holds an MSc degree in Experimental Therapeutics at the University of Oxford, UK, an MSc degree in Experimental Medicine at McGill University, Canada, and a PhD degree in health technology assessment at the University of Toronto, Canada.
Bassem has spent 28 years in diverse roles in hospital/healthcare, clinical research, pharmaceutical, medical device, biotechnology, and education. He is a WHO consultant, CEO and Founder of MD Pharma Consulting Group, ECFMG and LMCC Licensing Exams Program Director at Edge Plus Inc., health economist, pharmacovigilance consultant, clinical research instructor, and a mentor.
His areas of research include internal medicine, medical oncology, epidemiology, pharmacovigilance, health technology assessment, decision analysis, and benefit-risk assessment. My skills include bridging the gap between academia and industry, efficient resource allocation, time management, and task prioritization.
Bassem’s hardworking and persevering nature and compassionate demeanor make Bassem a sincere and passionate advocate for BeMe and Autistic individuals.
Bassem has worked in clinical practice, academia, and industry. In additional to having practiced Medicine, he holds an MSc degree in Experimental Therapeutics at the University of Oxford, UK, an MSc degree in Experimental Medicine at McGill University, Canada, and a PhD degree in health technology assessment at the University of Toronto, Canada.
Bassem has spent 28 years in diverse roles in hospital/healthcare, clinical research, pharmaceutical, medical device, biotechnology, and education. He is a WHO consultant, CEO and Founder of MD Pharma Consulting Group, ECFMG and LMCC Licensing Exams Program Director at Edge Plus Inc., health economist, pharmacovigilance consultant, clinical research instructor, and a mentor.
His areas of research include internal medicine, medical oncology, epidemiology, pharmacovigilance, health technology assessment, decision analysis, and benefit-risk assessment. My skills include bridging the gap between academia and industry, efficient resource allocation, time management, and task prioritization.
Bassem’s hardworking and persevering nature and compassionate demeanor make Bassem a sincere and passionate advocate for BeMe and Autistic individuals.
Ian has over 30 years of executive experience and specializes in scaling and managing technology businesses. He started his career at SST, where he led the company’s growth from start-up to over $25M in revenue. Since then, he has held a number of other C-level positions at $10M+ software businesses.
Ian is pleased to be an investor in BeMe as well as its CFO, where he will works with the executive team on financing and strategy.
